mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.093 |
0.8 |